Hillsdale Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-83,600
Closed -$6.07M 671
2024
Q1
$6.07M Buy
83,600
+6,500
+8% +$435K 0.48% 37
2023
Q4
$4.72M Sell
77,100
-200
-0.3% -$11.9K 0.39% 69
2023
Q3
$4.42M Hold
77,300
0.4% 71
2023
Q2
$4.59M Sell
77,300
-5,700
-7% -$341K 0.42% 72
2023
Q1
$5.2M Sell
83,000
-8,400
-9% -$524K 0.45% 75
2022
Q4
$5.72M Sell
91,400
-11,600
-11% -$665K 0.48% 50
2022
Q3
$5.13M Sell
103,000
-4,900
-5% -$271K 0.46% 65
2022
Q2
$6.34M Sell
107,900
-1,100
-1% -$60.6K 0.51% 38
2022
Q1
$5.77M Buy
109,000
+12,600
+13% +$728K 0.37% 78
2021
Q4
$5.85M Buy
96,400
+7,000
+8% +$416K 0.39% 75
2021
Q3
$5.02M Buy
89,400
+19,100
+27% +$1.05M 0.39% 75
2021
Q2
$3.66M Hold
70,300
0.29% 124
2021
Q1
$3.1M Hold
70,300
0.26% 133
2020
Q4
$2.45M Sell
70,300
-24,600
-26% -$874K 0.23% 135
2020
Q3
$3.46M Buy
94,900
+14,500
+18% +$539K 0.34% 84
2020
Q2
$3.02M Buy
80,400
+19,400
+32% +$776K 0.28% 108
2020
Q1
$2.24M Buy
+61,000
New +$2.37M 0.27% 117
2016
Q3
Sell
-6,800
Closed -$377K 546
2016
Q2
$377K Sell
6,800
-500
-7% -$27.5K 0.11% 192
2016
Q1
$390K Buy
+7,300
New +$360K 0.13% 167

Other funds holding PBH

Hillsdale Investment Management's PBH Position: Q2 2024 in Review

Hillsdale Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2024, closing a stake of 83,600 shares — an estimated $6.07M sold.

Hillsdale Investment Management first reported a position in PBH in Q1 2016 and held it in 19 quarters. The position peaked at $6.34M in Q2 2022. 306 funds tracked by Wall St. Rank hold PBH as of Q2 2024.

  • Hillsdale Investment Management reported no remaining Prestige Consumer Healthcare position as of Q2 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 83,600 Prestige Consumer Healthcare shares in Q2 2024, an estimated $6.07M.
  • Hillsdale Investment Management first reported a position in Prestige Consumer Healthcare in Q1 2016 and held it in 19 quarters.
  • Hillsdale Investment Management's Prestige Consumer Healthcare position peaked at $6.34M in Q2 2022.
  • 306 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2024.

Based on Hillsdale Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.